News & Updates
Filter by Specialty:

Ultrasensitive ctDNA detection predicts breast cancer relapse
13 Jun 2025
byStephen Padilla
A molecular residual disease (MRD) assay powered by whole genome sequencing (WGS) successfully detects breast cancer relapse, improving lead times for circulating tumour DNA (ctDNA) detection years ahead of clinical recurrence based on imaging.